Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.

Saved in:
Bibliographic Details
Title: Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
Authors: Kumar, Deepali1 (AUTHOR), Ison, Michael G2 (AUTHOR), Mira, Jean-Paul3 (AUTHOR), Welte, Tobias4 (AUTHOR), Hwan Ha, Jick5 (AUTHOR), Hui, David S6 (AUTHOR), Zhong, Nanshan7 (AUTHOR), Saito, Takefumi8 (AUTHOR), Katugampola, Laurie9 (AUTHOR), Collinson, Neil9 (AUTHOR), Williams, Sarah9 (AUTHOR), Wildum, Steffen10 (AUTHOR), Ackrill, Andrew9 (AUTHOR), Clinch, Barry9 (AUTHOR), Lee, Nelson1,11,12 (AUTHOR) nelsonls.lee@utoronto.ca
Source: Lancet Infectious Diseases. May2022, Vol. 22 Issue 5, p718-730. 13p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 156420383
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kumar%2C+Deepali%22">Kumar, Deepali</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ison%2C+Michael+G%22">Ison, Michael G</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mira%2C+Jean-Paul%22">Mira, Jean-Paul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Welte%2C+Tobias%22">Welte, Tobias</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hwan+Ha%2C+Jick%22">Hwan Ha, Jick</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hui%2C+David+S%22">Hui, David S</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhong%2C+Nanshan%22">Zhong, Nanshan</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saito%2C+Takefumi%22">Saito, Takefumi</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Katugampola%2C+Laurie%22">Katugampola, Laurie</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Collinson%2C+Neil%22">Collinson, Neil</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williams%2C+Sarah%22">Williams, Sarah</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wildum%2C+Steffen%22">Wildum, Steffen</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ackrill%2C+Andrew%22">Ackrill, Andrew</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Clinch%2C+Barry%22">Clinch, Barry</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+Nelson%22">Lee, Nelson</searchLink><relatesTo>1,11,12</relatesTo> (AUTHOR)<i> nelsonls.lee@utoronto.ca</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Infectious+Diseases%22">Lancet Infectious Diseases</searchLink>. May2022, Vol. 22 Issue 5, p718-730. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=156420383
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(21)00469-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 718
    Titles:
      – TitleFull: Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kumar, Deepali
      – PersonEntity:
          Name:
            NameFull: Ison, Michael G
      – PersonEntity:
          Name:
            NameFull: Mira, Jean-Paul
      – PersonEntity:
          Name:
            NameFull: Welte, Tobias
      – PersonEntity:
          Name:
            NameFull: Hwan Ha, Jick
      – PersonEntity:
          Name:
            NameFull: Hui, David S
      – PersonEntity:
          Name:
            NameFull: Zhong, Nanshan
      – PersonEntity:
          Name:
            NameFull: Saito, Takefumi
      – PersonEntity:
          Name:
            NameFull: Katugampola, Laurie
      – PersonEntity:
          Name:
            NameFull: Collinson, Neil
      – PersonEntity:
          Name:
            NameFull: Williams, Sarah
      – PersonEntity:
          Name:
            NameFull: Wildum, Steffen
      – PersonEntity:
          Name:
            NameFull: Ackrill, Andrew
      – PersonEntity:
          Name:
            NameFull: Clinch, Barry
      – PersonEntity:
          Name:
            NameFull: Lee, Nelson
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 14733099
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Lancet Infectious Diseases
              Type: main
ResultId 1